Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

820695

registered interest
date	11/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the take-up rate for cervical screening in (a) England, (b) North Yorkshire and (c) York was in 2017.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	122113
answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The National Health Service Cervical Screening Programme measures coverage rather than uptake rate. NHS England is responsible for monitoring the coverage rates for cervical screening in all age groups and is committed to improving coverage and reducing variation between all age groups.</p><p> </p><p>Data are provided by NHS Digital and are available at:</p><p> </p><p><a href="https://digital.nhs.uk/article/7035/Cervical-screening-programme-coverage" target="_blank">https://digital.nhs.uk/article/7035/Cervical-screening-programme-coverage</a></p><p> </p><p>General practitioner/clinical commissioning group level coverage is available at:</p><p> </p><p><a href="http://digital.nhs.uk/catalogue/PUB24229" target="_blank">http://digital.nhs.uk/catalogue/PUB24229</a></p><p> </p><p>The percentage of coverage for each area requested as at the end of 2016-17 is: England 72.0%; North Yorkshire 78.1%; York 73.0%.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/01/2018 11:48:21 answering member 4067 label Biography information for Steve Brine
tabling member	4471 label Biography information for Rachael Maskell

819897

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Oxford University Hospitals NHS Foundation Trust
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with Oxford University Hospitals NHS Foundation Trust on the recruitment and retention of specialist cancer staff in that trust; and if he will make a statement.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	121969
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>I spoke to Dr Bruno Holthof, Chief Executive of Oxford University Hospitals NHS Foundation Trust, on Wednesday 11 January. We discussed how the Trust is not currently changing cancer treatment regimes for its patients, or considering any change outside the standards set out by the National Institute for Health and Clinical Excellence. I also sought reassurance from the Trust that it is communicating effectively to patients, families and staff that there are no changes to cancer treatment programmes.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:45:06 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

819899

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Oxford University Hospitals NHS Foundation Trust: Chemotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will meet with the hon. member for Oxford West and Abingdon to discuss the availability of chemotherapy treatment offered by Oxford University Hospitals NHS Foundation Trust.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	121971
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>I will shortly be writing a detailed letter to the hon. member for Oxford West and Abingdon addressing her concerns about chemotherapy treatment at Oxford University Hospitals NHS Foundation Trust.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:51:02 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

819901

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Oxfordshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the reasons for shortages in chemotherapy nurses in Oxfordshire; and if he will make a statement.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	121973
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>Oxford University Hospitals NHS Foundation Trust continues to meet operational standards for providing cancer care to its patients. The most recent figures for Q2 2017/18 show:</p><p>- Two Week Wait from GP Urgent Referral to First Consultant Appointment: 96.9% (operational standard 95%);</p><p>- One Month Wait from a Decision to Treat to a First Treatment for Cancer: 97.0% (operational standard 95%); and</p><p>- Two Month Wait from GP Urgent Referral to a First Treatment for Cancer: 85.1% (operational standard 85%).</p><p> </p><p>We are committed to improving the capability and capacity of the cancer workforce in England. Health Education England (HEE) published its first ever Cancer Workforce Plan on 5 December 2017, setting out plans to increase the numbers working in cancer care, speeding up diagnoses and treatment.</p><p> </p><p>Macmillan Cancer Support are currently carrying out a Specialist Adult Cancer Nurse Census</p><p>to understand the current size and location of the specialist cancer nurse workforce. This will</p><p>enable HEE to develop a much more comprehensive picture of how many specialist nurses are working in cancer and what further action and investment might be required to ensure timely and good quality patient care and experience.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:46:13 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

819905

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Urinary Tract Infections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which minister in his Department will have responsibility for urological conditions.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	121977
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>Long-term conditions, such as, urological conditions are currently part of my portfolio.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:53:15 answering member 4067 label Biography information for Steve Brine
tabling member	4523 label Biography information for Catherine West

819960

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Migrant Workers
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many specialist cancer staff in (a) Oxfordshire and (b) England are non-UK EU citizens.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	122032
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>The specific level of detail required to answer this question is not available in the information held by NHS Digital relating to the National Health Service workforce.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:42:01 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

819973

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department’s Task and Finish Working Group on brain tumours plans to publish its report.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	122045
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>The Task and Finish Working Group on brain tumour’s latest estimate is that their work will be complete before the end of January 2018. The Working Group is undertaking a challenging task in this difficult area. Inputs are being sought from many stakeholders in order to produce a useful and impactful report. Some of these stakeholders are very busy clinicians, and need to be given sufficient time to formulate their inputs – we are committed to involving them.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:44:10 answering member 4067 label Biography information for Steve Brine
tabling member	1400 label Biography information for Kevin Brennan

820016

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of provision of FLUAD for those aged over 65 this winter.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122088
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>The adjuvanted trivalent influenza vaccine was not available for use in 2017/18. However, the Joint Committee on Vaccination and Immunisation (JCVI) considered the effectiveness of this vaccine for future years in October 2017. The minutes of the JCVI meeting are available at:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation</a></p><p>Following the JCVI meeting, Public Health England updated their advice in the Green Book chapter on influenza so that clinicians are aware of the advice of the JCVI in relation to the adjuvanted trivalent influenza vaccine.</p><p> </p><p>In addition, NHS England wrote to general practitioners (GPs) and clinical commissioning groups (via NHS England local teams) in December 2017 to provide an update on the use of the adjuvanted trivalent influenza vaccine for 2018/19. This update will also be made available to community pharmacies as part of confirming that the Advanced Influenza Vaccination service has been recommissioned in early 2018. Community pharmacies are able to order relevant vaccines as detailed in the service specification, including the enhanced vaccine for patients within the relevant cohort.</p><p> </p><p>GPs and pharmacies are responsible for ordering and purchasing flu vaccines for the adult seasonal flu programme (eligible individuals aged 18 years and over) directly from manufacturers based on the published advice.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122089 122090 question first answered 15/01/2018 17:57:17 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

820017

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, on what date he informed GPs and pharmacies of the recommendations of the Joint Committee on Vaccination and Immunisation on FLUAD.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122089
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>The adjuvanted trivalent influenza vaccine was not available for use in 2017/18. However, the Joint Committee on Vaccination and Immunisation (JCVI) considered the effectiveness of this vaccine for future years in October 2017. The minutes of the JCVI meeting are available at:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation</a></p><p>Following the JCVI meeting, Public Health England updated their advice in the Green Book chapter on influenza so that clinicians are aware of the advice of the JCVI in relation to the adjuvanted trivalent influenza vaccine.</p><p> </p><p>In addition, NHS England wrote to general practitioners (GPs) and clinical commissioning groups (via NHS England local teams) in December 2017 to provide an update on the use of the adjuvanted trivalent influenza vaccine for 2018/19. This update will also be made available to community pharmacies as part of confirming that the Advanced Influenza Vaccination service has been recommissioned in early 2018. Community pharmacies are able to order relevant vaccines as detailed in the service specification, including the enhanced vaccine for patients within the relevant cohort.</p><p> </p><p>GPs and pharmacies are responsible for ordering and purchasing flu vaccines for the adult seasonal flu programme (eligible individuals aged 18 years and over) directly from manufacturers based on the published advice.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122088 122090 question first answered 15/01/2018 17:57:17 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

820018

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to increase the availability of FLUAD for those aged over 65 in 2018-19.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	122090
answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>The adjuvanted trivalent influenza vaccine was not available for use in 2017/18. However, the Joint Committee on Vaccination and Immunisation (JCVI) considered the effectiveness of this vaccine for future years in October 2017. The minutes of the JCVI meeting are available at:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation</a></p><p>Following the JCVI meeting, Public Health England updated their advice in the Green Book chapter on influenza so that clinicians are aware of the advice of the JCVI in relation to the adjuvanted trivalent influenza vaccine.</p><p> </p><p>In addition, NHS England wrote to general practitioners (GPs) and clinical commissioning groups (via NHS England local teams) in December 2017 to provide an update on the use of the adjuvanted trivalent influenza vaccine for 2018/19. This update will also be made available to community pharmacies as part of confirming that the Advanced Influenza Vaccination service has been recommissioned in early 2018. Community pharmacies are able to order relevant vaccines as detailed in the service specification, including the enhanced vaccine for patients within the relevant cohort.</p><p> </p><p>GPs and pharmacies are responsible for ordering and purchasing flu vaccines for the adult seasonal flu programme (eligible individuals aged 18 years and over) directly from manufacturers based on the published advice.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122088 122089 question first answered 15/01/2018 17:57:17 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon